NCI Funding Opportunities Forum
On September 9th, MBC hosted dozens of cancer research companies at a forum to learn about new funding opportunities being offered by the National Cancer Institute.
Michael Weingarten and David Beylin from NCI's SBIR program outlined 18 new contract funding opportunities for biotech companies in the cancer research field. The NCI programs offer funding in nanotechnology, anti-cancer agents, biomarkers, proteomics, pharmacodynamics, and many more areas of interest to the NCI.
The presentation made by Mr. Weingarten can be found here.
The event was co-sponsored by the Massachusetts Technology Transfer Center.